arixtra2.5 amb

Arixtra 2.5 mg is an injectable anticoagulant containing fondaparinux sodium. It is a synthetic selective inhibitor of activated Factor X (Xa), which plays a critical role in the blood coagulation cascade. Arixtra is widely prescribed to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopedic or abdominal surgeries. It is also utilized in the management of acute coronary syndromes, including unstable angina and myocardial infarction. The pre-filled syringe is designed for subcutaneous administration, offering a predictable antithrombotic effect with a low risk of heparin-induced thrombocytopenia.